Minimal clinically important differences for the EQ-5D and QWB-SA in Post-traumatic Stress Disorder (PTSD): Results from a Doubly Randomized Preference Trial (DRPT)

Health and Quality of Life Outcomes

Volumn 11, Issue 1, 2013, Pages

  Le, Quang A ^a   Doctor, Jason N ^b   Zoellner, Lori A ^c   Feeny, Norah C ^d  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Doubly randomized preference trial; EQ 5D; Minimal clinically important difference; Prolonged exposure therapy; PTSD; QWB SA; Sertraline

Indexed keywords

SERTRALINE;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL GLOBAL IMPRESSION SCALE; COGNITIVE THERAPY; EUROQOL 5 DIMENSION; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH SERVICE; POSTTRAUMATIC STRESS DISORDER; QUALITY OF LIFE; QUALITY OF LIFE INDEX; QUALITY OF WELL BEING SELF ADMINISTERED SCALE; SCORING SYSTEM; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; COGNITIVE THERAPY; EPILEPSY, POST-TRAUMATIC; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; PATIENT PREFERENCE; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; REGRESSION ANALYSIS; RESEARCH DESIGN; ROC CURVE; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84876962029     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-11-59     Document Type: Article

References (37)

1. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1995, 52:1048-60. 10.1001/archpsyc.1995.03950240066012, 7492257.
2. Hoge CW, Castro CA, Messer SC, McGurk D, Cotting DI, Koffman RL. Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care. N Engl J Med 2004, 351:13-22. 10.1056/NEJMoa040603, 15229303.
3. Mendlowicz MV, Stein MB. Quality of life in individuals with anxiety disorders. Am J Psychiatry 2000, 157:669-682. 10.1176/appi.ajp.157.5.669, 10784456.
4. Sareen J, Cox BJ, Stein MB. Physical and mental disability, disability, and suicidal behavior associated with posttraumatic stress disorder in a large community sample. Psychosom Med 2007, 69:242-248. 10.1097/PSY.0b013e31803146d8, 17401056.
5. Doctor JN, Zoellner LA, Feeny NC. Predictors of health-related quality-of-life utilities among persons with posttraumatic stress disorder. Psych Serv 2011, 62:272-277.
6. Greenberg PE, Sisitsky T, Kessler RC. The economic burden of anxiety disorders in the 1990s. J Clin Psychiatry 1999, 60:427-35. 10.4088/JCP.v60n0702, 10453795.
7. Eibner C, Ringel JS, Kilmer B, Pacula RL, Diaz C. The cost of post-deployment mental health and cognitive conditions. Invisible wounds of war: psychological and cognitive injuries, their consequences, and services to assist recovery 2008, Santa Monica: RAND, Tanielian T, Jaycox LH.
8. Foa E, Riggs DS, Dancu CV, Rothbaum BO. Reliability and validity of a brief instrument for assessing post-traumatic stress disorder. J Trauma Stress 1993, 6:459-74.
9. Blanchard EB, Jones-Alexander J, Buckley TC, Forneris CA. Psychometric properties of the PTSD checklist (PCL). Behav Res Ther 1996, 34:669-673. 10.1016/0005-7967(96)00033-2, 8870294.
10. Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Gusman FD, Charney DS, Keane TM. The development of a clinician-administered PTSD scale. J of Trauma Stress 1995, 8:75-90.
11. Mancino MJ, Pyne JM, Tripathi S, Constans J, Roca V, Freeman T. Quality-adjusted health status in veterans with posttraumatic stress disorder. J Nerv Ment Dis 2006, 194:877-879. 10.1097/01.nmd.0000244686.79689.21, 17102715.
12. Freed MC, Yeager DE, Liu X, Gore KL, Engel CC, Magruder KM. Preference-weighted health status of PTSD among veterans: an outcome for cost-effectiveness analysis using clinical data. Psych Serv 2009, 60:1230-1238.
13. Cohen BE, Marmar CR, Neylan TC, Schiller NB, Ali S, Whooley MA. Posttraumatic stress disorder and health-related quality of life in patients with coronary heart disease: findings from the Heart and Soul study. Arch Gen Psychiatry 2009, 66:1214-1220. 10.1001/archgenpsychiatry.2009.149, 2822711, 19884609.
14. Haagsma JA, Polinder S, Olff M, Toet H, Bonsel GJ, van Beeck EF. Posttraumatic stress symptoms and health-related quality of life: a two year follow up study of injury treated at the emergency department. BMC Psychiatry 2012, 12:1. 10.1186/1471-244X-12-1, 3276433, 22230388.
15. Walter SJ, Brazier JE. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res 2005, 14:1523-1532. 10.1007/s11136-004-7713-0, 16110932.
16. Revicki DA, Cella D, Hays RD, Sloan JA, Lenderking WR, Aaronson NK. Responsiveness and minimal important differences for patient reported outcomes. Health Qual Life Outcomes 2006, 4:70. 10.1186/1477-7525-4-70, 1586195, 17005038.
17. Revicki DA, Hays RD, Cella D, Sloan JA. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol 2008, 61:102-109. 10.1016/j.jclinepi.2007.03.012, 18177782.
18. Pickard SA, Neary MP, Cella D. Estimation of minimally important differences in EQ-5D and VAS scores in cancer. Health Qual Life Outcomes 2007, 5:70. 10.1186/1477-7525-5-70, 2248572, 18154669.
19. Coteur G, Feagan B, Keininger DL, Kosinski M. Evaluation of the meaningfulness of health-related quality of life of life improvements as assessed by the SF-36 and the EQ-5D VAS in patients with active Crohn's disease. Aliment Pharmocol Ther 2009, 29:1032-1041.
20. Luo N, Johnson JA, Coons SJ. Using instrument-defined health state transitions to estimate minimally important differences for four preference-based health-related quality of life instruments. Med Care 2010, 48:365-371. 10.1097/MLR.0b013e3181c162a2, 20355266.
21. McDonough CM, Tosteson TD, Tosteson ANA, Jette AM, Grove MR, Weinstein JN. A longitudinal comparison of 5 preference-weighted health state classification systems in persons with intervertebral disk herniation. Med Dec Making 2011, 31:270-280.
22. Kaplan RM. The minimally clinically important difference in generic utility-based measures. COPD 2005, 2:91-97. 10.1081/COPD-200052090, 17136968.
23. Kupferberg DH, Kaplan RM, Slymen DJ, Ries AL. Minimal clinically important difference for the UCSD shortness of breath questionnaire. J Cardiopulm Rehabil 2005, 25:370-377. 10.1097/00008483-200511000-00011, 16327533.
24. Kind P. Guidelines for value sets in economic and on-economic studies using EQ-5D. The Measurement and Valuation of Health Status Using EQ-5D: A European Perspective 2003, 29-42. Amsterdam: the Netherlands Kluwer Academic Publishers, Brooks R, Rabin R, Charro FD.
25. Shaw JW, Johnson JA, Coons SJ. US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med care 2005, 43:203-20. 10.1097/00005650-200503000-00003, 15725977.
26. Kaplan RM, Sieber WJ, Ganiats TG. The Quality of Well-Being Scale: Comparison of the interviewer-administered version with a self-administered questionnaire. Psychol Health 1977, 12:783-791.
27. National Institute of Mental Health (NIMH) Early clinical drug evaluation unit (ECDEU) Clinical global impressions. ECDEU Assessment Manual for Psychopharmacology Revised 1976, 218-222. Rockville, MD: NIMH, Guy W, National Institute of Mental Health (NIMH) Early clinical drug evaluation unit (ECDEU).
28. Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 1991, 59:12-19.
29. Jacobson NS, Roberts LJ, Berns SB, McGlinchey JB. Methods for defining and determining the clinical significance of treatment effects: description, application, and alternatives. J Consult Clin Psychol 1999, 67:300-307.
30. Foa EB, Cashman LJ, Jaycox LH, Perry K. The validation of a self-report measure of PTSD: The PTSD Diagnostic Scale. Psychol Assess 1997, 9:445-451.
31. Miller KL, Walt JG, Mink DR. Minimal clinically important difference for the ocular surface disease index. Arch Ophthalmol 2010, 128:94-101. 10.1001/archophthalmol.2009.356, 20065224.
32. Hanley JA, McNeil BJ. The meaning and use of the area under a receiving operating characteristic (ROC) curve. Radiology 1982, 143:29-36.
33. Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures: statistics and strategies for evaluation. Control Clin Trials 1991, 12:142S-158S. 10.1016/S0197-2456(05)80019-4, 1663851.
34. Ward MM, Marx AS, Barry NN. Identification of clinically important changes in health status using receiver operating characteristic curves. J Clin Epidemiol 2000, 53:279-284. 10.1016/S0895-4356(99)00140-7, 10760638.
35. Turner D, Schunemann HJ, Griffith LE. Using the entire cohort in the receiver operating characteristic analysis maximizes precision of the minimal important difference. J Clin Epidemiol 2009, 62:374-379. 10.1016/j.jclinepi.2008.07.009, 19013766.
36. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003, 41:582-592.
37. Crosby RD, Kolotkin RL, Williams RG. Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol 2005, 56:395-407.